Chemours vs Tronox
CC and TROX side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CC and TROX compare
Chemours is the larger company, worth 4.6 times as much as Tronox ($2.1B against $450M).
Tronox grew revenue faster over the last twelve months (12.0% versus 0.07% for Chemours).
Chemours keeps more of each dollar of sales as profit, with a net margin of −2.6% compared with −15.9% at Tronox.
Both pay dividends: Chemours yields 2.6% and Tronox 5.3%.
Tronox scores higher on the StockData Score (8 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CC | TROX |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $450M |
| Share price | $13.72 | $2.82 |
| Change, 1 year | 7.6% | −21.9% |
| Change, 5 years | −56.8% | −87.9% |
| Beta (5Y) | 1.57 | 1.68 |
| Employees | 5,700 | 5,700 |
| StockData Score | ||
| Total score | 5 | 8 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/S | 0.4× | 0.1× (better) |
| P/B | 13.3× | 0.4× (better) |
| EV/EBITDA | 7.2× (better) | 24.5× |
| P/FCF | 9.8× | – |
| FCF yield | 10.2% (better) | −3.8% |
| Fair value | – | $12.93 |
| Margin of safety | – | 78.2% |
| Growth | ||
| Revenue growth (TTM) | 0.07% | 12.0% (better) |
| Revenue growth, 5Y average | 3.2% (better) | 1.00% |
| Profitability | ||
| Gross margin | 15.2% (better) | 6.8% |
| Operating margin | – | −5.1% |
| Net margin | −2.6% (better) | −15.9% |
| FCF margin | 3.6% (better) | −0.53% |
| Return on equity | −71.8% | −37.6% (better) |
| Return on invested capital | – | −2.9% |
| Financial health | ||
| Debt / equity | 24.73 | 2.85 (better) |
| Net debt / EBITDA | 4.32 (better) | 21.14 |
| Interest coverage | – | −0.7× |
| Current ratio | 1.81 | 2.52 (better) |
| Altman Z-score | 1.42 (better) | 0.69 |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% | 5.3% (better) |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −12.5% | 4.6% (better) |
| Shareholder yield | 2.6% | 5.3% (better) |
| Ownership | ||
| Held by institutions | 90.2% | 77.8% |
| Held by insiders | 0.96% | 2.6% |
| Insider net buying, 12 months | $489K (better) | −$1.2M |
| Short interest, % of float | 9.8% | 11.8% |
Go deeper
- CC stock overview
- CC income statement
- CC valuation and score
- TROX stock overview
- TROX income statement
- TROX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.